Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Cardiac Damage With CMR in Women With Breast Cancer

NCT04046315 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT04046315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04046315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Cardiac Damage With CMR in Women With Breast Cancer
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2020
Completion date
March 31, 2021
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiotoxicity, chemotherapy induced systolic dysfunction